Scholarlink

<p>The healthcare sector faces pressure due to increased demands due to an aging population, staff shortages and rising costs. Moreover, it significantly contributes to greenhouse gas emissions. To ensure healthcare remains accessible and sustainable in the future, drastic changes are necessary. In uro-oncology, there are several successful examples of care de-escalation, such as active surveillance for low-risk prostate cancer and T1a kidney tumors. Strategies like hypofractionation in radiotherapy and alternative follow-up methods, such as urine testing for bladder cancer, can reduce hospital visits while improving healthcare capacity. A&#xa0;reduction in the number of hospital visits by patients has a&#xa0;positive environmental impact and results in increased healthcare capacity. New systemic therapies for renal- and bladder cancer, such as immunotherapy, demonstrated improved patient survival in studies. However, this survival benefit is less prominent in daily practice. Therefore, it is imperative to critically evaluate how studies were conducted. Patients should have access to medicines proven to be effective, with limited side-effects and costs. This sometimes means refraining from adopting new therapies, and using existing treatments more rationally. Studies are currently being conducted to determine how available systemic therapies can be used more efficiently and effectively. Alongside optimizing scarce healthcare resources, prevention plays a&#xa0;vital role, with an emphasis on smoking cessation and promoting a&#xa0;healthy lifestyle. By adopting efficient and sustainable practices, we can safeguard the accessibility and sustainability of healthcare for the future.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

De toekomst van de uro-oncologische zorg: minder is meer?

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年2月19日

查看全文
  • Vera C. Rutten,
  • Bart M. F. Penninx,
  • Hans M. Westgeest,
  • Joost L. Boormans

摘要

The healthcare sector faces pressure due to increased demands due to an aging population, staff shortages and rising costs. Moreover, it significantly contributes to greenhouse gas emissions. To ensure healthcare remains accessible and sustainable in the future, drastic changes are necessary. In uro-oncology, there are several successful examples of care de-escalation, such as active surveillance for low-risk prostate cancer and T1a kidney tumors. Strategies like hypofractionation in radiotherapy and alternative follow-up methods, such as urine testing for bladder cancer, can reduce hospital visits while improving healthcare capacity. A reduction in the number of hospital visits by patients has a positive environmental impact and results in increased healthcare capacity. New systemic therapies for renal- and bladder cancer, such as immunotherapy, demonstrated improved patient survival in studies. However, this survival benefit is less prominent in daily practice. Therefore, it is imperative to critically evaluate how studies were conducted. Patients should have access to medicines proven to be effective, with limited side-effects and costs. This sometimes means refraining from adopting new therapies, and using existing treatments more rationally. Studies are currently being conducted to determine how available systemic therapies can be used more efficiently and effectively. Alongside optimizing scarce healthcare resources, prevention plays a vital role, with an emphasis on smoking cessation and promoting a healthy lifestyle. By adopting efficient and sustainable practices, we can safeguard the accessibility and sustainability of healthcare for the future.